
Abstract 450: Systems biology approach provides rationale for dual-targeted inhibition of BET and CHK1 in aggressive pediatric osteosarcoma
Author(s) -
Khadijeh Bijangi-Vishehsaraei,
Pankita H. Pandya,
Lijun Cheng,
Shan Tang,
Anthony L. Sinn,
Melissa A. Trowbridge,
Kathy Coy,
Courtney Hemenway,
Barbara J. Bailey,
Harlan E. Shan,
Junhua Ding,
Erika A. Dobrota,
M. Reza Saadatzadeh,
Adily Elmi,
Jeremiah Shultz,
Mary Ellen Murray,
Mark S. Marshall,
Michael J. Ferguson,
Todd Bertrand,
L. Daniel Wurtz,
Sandeep Batra,
Lang Li,
Jamie Renbarger,
Karen E. Pollok
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-450
Subject(s) - copy number variation , targeted therapy , cancer research , medicine , biomarker , gene , oncology , cancer , biology , genetics , genome